Search This Blog

Tuesday, August 6, 2019

Editas Medicine EPS misses by $0.06, misses on revenue

Editas Medicine (NASDAQ:EDIT): Q2 GAAP EPS of -$0.69 misses by $0.06.
Revenue of $2.33M (-68.4% Y/Y) misses by $4.55M.
Shares -1.3%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)